Search
Processa Pharmaceuticals Inc
PCSAAdd to Watchlist
2.160USD
+0.200+10.20%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
5.78MMarket Cap
LossP/E TTM
Processa Pharmaceuticals Inc Earnings Date
Period
FY2025 Earnings Date
Revenue(YoY)
--
--
EPS(YoY)
-10.36
89.30%
Analyst Rating
2026-07-04
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What are the current assets of Processa Pharmaceuticals Inc?
According to Processa Pharmaceuticals Inc's FY2025 earnings report, its current assets were 5.67M, with a year-on-year change of 202.67.
What are the total assets of Processa Pharmaceuticals Inc?
According to Processa Pharmaceuticals Inc's FY2025 earnings report, its total assets of Processa Pharmaceuticals Inc were 7.81M, with a year-on-year change of 141.96.
What are the total liabilities of Processa Pharmaceuticals Inc?
According to Processa Pharmaceuticals Inc's FY2025 earnings report, its total liabilities of Processa Pharmaceuticals Inc were 2.24M, with a year-on-year change of 45.86.
What is the total equity of Processa Pharmaceuticals Inc?
According to Processa Pharmaceuticals Inc's FY2025 earnings report, its total equity of Processa Pharmaceuticals Inc was 5.58M, with a year-on-year change of 228.82.
What is the net investment of Processa Pharmaceuticals Inc?
According to Processa Pharmaceuticals Inc's FY2025 earnings report, its net investment of Processa Pharmaceuticals Inc was -850.00K, with a year-on-year change of -26102.22.
What is the net financing of Processa Pharmaceuticals Inc?
According to Processa Pharmaceuticals Inc's FY2025 earnings report, its net financing of Processa Pharmaceuticals Inc was 16.58M, with a year-on-year change of 114.40.
What is the Earnings Per Share (EPS) of Processa Pharmaceuticals Inc?
According to Processa Pharmaceuticals Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -10.36, with a year-on-year change of 89.30.
What is the Return on Equity (ROE) of Processa Pharmaceuticals Inc?
According to Processa Pharmaceuticals Inc's FY2025 earnings report, its Return on Equity (ROE) was -372.97, with a year-on-year change of -5.21.
What is the Return on Assets (ROA) of Processa Pharmaceuticals Inc?
According to Processa Pharmaceuticals Inc's FY2025 earnings report, its Return on Assets (ROA) was -245.66, with a year-on-year change of 6.55.
What is the operating profit of Processa Pharmaceuticals Inc?
According to Processa Pharmaceuticals Inc's FY2025 earnings report, its operating profit was -13.99M, with a year-on-year change of -16.08.